Clinical Trials List
2021-08-01 - 2023-12-31
Phase II
Terminated8
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wei-An Chang 無
- Ying-Ming Tsai Tsai 無
- 蔡毓真 無
- 鄭至宏 無
- Jen-Yu Hung 無
- 陳家閔 無
- Ming-Ju Tsai 無
- Chih-Jen Yang 無
- Hung-Ling Huang 無
- Inn-Wen Chong 無
- KUAN-LI WU 無
- 李玫萱 無
- jong rung Tsai 無
- 鄭孟軒 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Horng-Chyuan Lin 無
- 林倡葦 無
- Fu-Tsai Chung 無
- 黃鴻育 無
- 羅君禹 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 游騰仁 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
322 participants
